Month: September 2017

After Trump’s failed efforts to repeal and replace Obamacare, Trump introduced the “skinny” repeal that calls for doing away with parts of Affordable Care Act (ACA) or Obamacare like “individual mandate,” “employer mandate” and “Cadillac taxes”. Last month, the Republicans lost the debate over skinny repeal. The United States witnessed a political dilemma after three Republicans voted in favor of the existing Healthcare Act […]

Arthur J. Gallagher & Co AJG recently acquired National Transportation Adjusters, Inc., via its subsidiary, Gallagher Bassett Services, Inc. […]

Leading cable multi service operator (MSO) and media giant Comcast Corp. CMCSA has reportedly started testing the integration of YouTube on its X1 video platform. The company, however, did not reveal the number of markets and customers involved in the test […]

On Sunday, North Korea raised global geopolitical tensions after it claimed it had conducted a sixth and substantially more powerful nuclear test. This announcement also significantly increased pressure on the Trump administration, representing the most serious foreign affairs crisis in years. Much of this depends on how the United States ultimately responds to this latest provocation from North Korea. […]

Value investing is easily one of the most popular ways to find great stocks in any market environment. After all, who wouldn’t want to find stocks that are either flying under the radar and are compelling buys, or offer up tantalizing discounts when compared to fair value? One way to find these companies is by looking at several key metrics and financial ratios, many of which are crucial in the value stock selection process. […]

Pfizer Inc. PFE announced that the FDA has granted approval to Mylotarg for adult patients with newly diagnosed CD33-positive acute myeloid leukemia (AML). The drug also received approval to treat relapsed or refractory CD33-positive AML in adults as well as children (2 years and older) […]

Per the theory of cost of capital, a company’s capital structure reflects a mix of debt and equity that are used to finance its capital projects. Now a comparative analysis of the same theory reveals that most companies prefer debt financing over equity since debt is cheaper, especially in periods of low interest rates. This is because when a company resorts to debt financing, it takes on fixed expenses in the form of interest payments for a specific time period. […]

Per Bloomberg, oil producer Canadian Natural Resources Limited CNQ might be the one to acquire Cenovus Energy Inc.'s CVE asset in Pelican Lake, Alberta, Canada. Canadian Natural will pay C$1 billion ($807 million) for the property. Canadian Natural and Cona Resources Ltd. […]

Value investing is easily one of the most popular ways to find great stocks in any market environment. After all, who wouldn’t want to find stocks that are either flying under the radar and are compelling buys, or offer up tantalizing discounts when compared to fair value? One way to find these companies is by looking at several key metrics and financial ratios, many of which are crucial in the value stock selection process. […]

Shares of Mazor Robotics Ltd. MZOR , rallied to a new 52-week high of $49.64 on Sep 1, eventually closing a little lower at $49.23. The stock currently carries a Zacks Rank #2 (Buy) […]

Premium robotics and power grid solutions provider ABB Ltd ABB recently announced partnerships with Amazon.com, Inc. AMZN and Sonos, at Europe’s consumer electronics show, IFA, in Berlin. ABB is collaborating with other market behemoths to offer an integrated experience of connected and software-enabled solutions for consumers […]

Ryanair Holdings plc RYAAY unveiled a busy London schedule for the summer of 2018, even as it reiterated Brexit-related fears. The schedule announced by the low-cost carrier features a record of 168 routes. The carrier aims to transport 24.8 million customers this year from the three London airports — Stansted, Gatwick and Luton. […]

Federal Realty Investment Trust FRT is making diligent efforts to sell its non-core assets and redeploy the proceeds toward strategic growth schemes. Recently, the company announced that it has sold 150 Post Street — an office and retail property spanning 105,000 square feet of space — for $69.3 million. […]

Value investing is easily one of the most popular ways to find great stocks in any market environment. After all, who wouldn’t want to find stocks that are either flying under the radar and are compelling buys, or offer up tantalizing discounts when compared to fair value? One way to find these companies is by looking at several key metrics and financial ratios, many of which are crucial in the value stock selection process […]

Loews Corporation L stands on a firm ground for growth, given its market focus, strategic acquisitions and a solid balance sheet. The Zacks Rank #3 (Hold) insurer looks promising, banking on several growth drivers. Growth Projections : The Zacks Consensus Estimate for earnings per share is $3.05 on revenues of $13.2 billion for 2017 […]

Value investing is easily one of the most popular ways to find great stocks in any market environment. After all, who wouldn’t want to find stocks that are either flying under the radar and are compelling buys, or offer up tantalizing discounts when compared to fair value? One way to find these companies is by looking at several key metrics and financial ratios, many of which are crucial in the value stock selection process. […]

Shares of GOL Linhas Aereas Inteligentes S.A. GOL hit a 52-week high of $18.73 during the trading session on Sep 1, before retracing a bit to close at $18.17. […]

The FDA, which approved 22 novel drugs last year, has given its approval to 31 drugs so far in 2017 including five in August. Key approvals this year include Gilead’s Vosevi (hepatitis C virus), Puma’s Nerlynx (to reduce the risk of breast cancer returning), J&J’s Tremfya (moderate-to-severe plaque psoriasis), Regeneron/Sanofi’s Kevzara (rheumatoid arthritis), Roche’s multiple sclerosis treatment, Ocrevus, Regeneron and Sanofi’s eczema treatment, Dupixent, Tesaro’s PARP inhibitor, Zejula, and BioMarin’s Brineura (treatment of a specific form of Batten disease) among others. Some of these drugs have blockbuster potential […]

Eastman Chemical EMN announced a number of expansion projects to increase CHDM capacity by 15,000 metric tons at its Kingsport, TN, manufacturing facility. Spanning over a period of 18 months, these projects are expected to be completed by early 2019. […]

Ford Motor Company F announced issuing of two safety recalls as well as two safety compliances in North America. The recalled vehicles will be Ford F-150 and Mustang vehicles, Ford Explorer, Taurus and Police Interceptor Utility and Sedan vehicles. […]